AION Labs

Thank you Moshe Bar Siman Tov and משרד הבריאות Israel Ministry of Health for your support and partnership Anat Boehm-Cagan (ענת בם-כגן) Sarit Steinberg Ohad Goldberg Ezequiel Garfinkel Mati Gill Yair Benita

Today we hosted the Israel Innovation Authority venture studio and venture incubators forum at AION Labs to discuss ways to promote the #deeptech and #bioconvergence #ecosystem of Israel 🇮🇱 and shared insights from operations in our two years of company building. The Israel Innovation Authority continues to be a driving force for the hi-tech ecosystem of Israel! Hanan Brand Chai Avital Shomrat Shurtz Shlomi Kofman @zachi Schnarch Noga Carmin נגה כרמין Tal Leibovich-Rivkin DenovAI Biotech Israel Innovation Authority רשות החדשנות Linoy Simhi Nirit Ossi Einav Daniel Mati Gill

Save the date! On September 4, AION Labs CEO Mati Gill will speak at GBX EVENTS’ 15th Annual Drug Discovery Innovation Forum in Berlin, addressing the issue of how #AI innovation is meeting critical pharmaceutical challenges head-on! Discussion topics will include: ➡️ Creating the right model that fosters collaboration and growth.  ➡️ The central role of AI and computational biology in addressing critical therapeutic R&D challenges. ➡️ How Israel is poised to become a global hub for pharma innovation. To learn more and register, visit: https://lnkd.in/d8EFpTuh #AI #ML #DDIF2024 #DDIF #Innovation

Congratulations to TenAces Biosciences Bioinformatics lead Chen Lior on culmination of her #PhD at the Weizmann Institute of Science !

“Israel can and is playing a competitive role in the future of our ecosystem...where the tech components of machine learning and #AI technologies really need to be domain expertise” ~ AION Labs’ CEO Mati Gill on the main stage at #HLTHEurope discussing the critical needs of the pharmaceutical industry and how Israel is primed to play a central role in the future of biotech #innovation. Mike Devoy, Jim Swanson, Nicole Büttner, HLTH Europe

Congratulations to our partners BioMed X Institute on the launch of their new US 🇺🇸campus at Yale University ! Christian Tidona Mark Johnston Yvonne Stappenbeck

Attending Exporttag 2024 next week? Don’t miss Mati Gill’s presentation explaining our unique venture studio model and how AION Labs is setting a new paradigm for #AI pharma #startup creation! Join Mati in Vienna on Tuesday, June 18, at 4:30pm CET!

#AI has the potential to impact the whole spectrum of drug discovery and development, from initial concept to regulatory approval and beyond. Mati Gill sat down with Amar Drawid, Ph.D. from Levine Media Group’s Life Sciences D’n’A podcast to discuss our unique venture studio model for discovering the talent that can solve major pharma R&D challenges. Check out the full episode: https://lnkd.in/dMUE3G_B

One week to go until #HTLHEurope 2024!  Make sure to catch Mati Gill on the main stage with Mike Devoy, Jim Swanson, and Nicole Büttner for the keynote: “Is #AI Pharma’s Golden Pill?” HLTH Europe, Johnson & Johnson, Bayer, Merantix Momentum #biotech #digitalhealth #innovation

Welcome Laura Matz to AION Labs!   We are thrilled to welcome Laura to our AION Labs Board of Directors! As the Chief Science and Technology Officer for Merck KGaA, Darmstadt, Germany, Laura drives innovation and digitalization across the 3 business sectors, Life Sciences, Healthcare, and Electronics. We look forward to working with Laura as we continue to propel #innovation to tackle the most pressing #therapeutic challenges.